Alibaba Health Information Technology Limited (HKG:0241)
Hong Kong · Delayed Price · Currency is HKD 3.590
+0.060 (1.70%)
Jul 31, 2026, 4:08 PM HKT
HKG:0241 Income Statement
Financials in millions CNY. Fiscal year is April - March.
Millions CNY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 34,255 | 30,598 | 27,027 | 26,763 | 20,578 | |
Revenue Growth | 11.95% | 13.22% | 0.98% | 30.06% | 32.60% |
Cost of Revenue | 26,045 | 23,166 | 21,131 | 21,062 | 16,470 |
Gross Profit | 8,210 | 7,432 | 5,895 | 5,701 | 4,108 |
Selling, General & Admin | 5,586 | 5,234 | 4,550 | 5,055 | 4,474 |
Research & Development | 788.35 | 720.05 | 705.38 | 677.82 | 728.83 |
Other Operating Expenses | 7.6 | 24.88 | 5.33 | 19.72 | 3.95 |
Operating Expenses | 6,382 | 5,978 | 5,260 | 5,753 | 5,206 |
Operating Income | 1,829 | 1,454 | 634.85 | -51.5 | -1,098 |
Interest Expense | -1.4 | -2.61 | -5.97 | -5.83 | -3.82 |
Interest & Investment Income | 488.08 | 488.57 | 508.56 | 331.59 | 213.58 |
Earnings From Equity Investments | 2.17 | -64.66 | -5.93 | 11.38 | -45.62 |
Currency Exchange Gain (Loss) | 32.34 | -37.14 | 7.09 | 72.06 | 39.7 |
Other Non Operating Income (Expenses) | 97.03 | 121.02 | 92.17 | 99.17 | 102.54 |
EBT Excluding Unusual Items | 2,447 | 1,959 | 1,231 | 456.86 | -792.05 |
Impairment of Goodwill | -5.52 | - | - | - | - |
Gain (Loss) on Sale of Investments | -176.07 | -399.45 | -283.44 | 114.89 | 542.1 |
Gain (Loss) on Sale of Assets | 8.96 | 0.62 | 0.53 | -1.24 | 0.14 |
Other Unusual Items | 0.04 | -0.03 | -8.46 | -19.51 | -2.71 |
Pretax Income | 2,274 | 1,560 | 939.4 | 550.99 | -252.51 |
Income Tax Expense | 337.88 | 127.95 | 56.26 | 14.49 | 13.43 |
Earnings From Continuing Operations | 1,936 | 1,432 | 883.14 | 536.51 | -265.94 |
Minority Interest in Earnings | -0.18 | 0.41 | 0.34 | -0.86 | 0.39 |
Net Income | 1,936 | 1,432 | 883.48 | 535.65 | -265.56 |
Net Income to Common | 1,936 | 1,432 | 883.48 | 535.65 | -265.56 |
Net Income Growth | 35.17% | 62.13% | 64.94% | - | - |
Shares Outstanding (Basic) | 16,110 | 16,071 | 14,044 | 13,503 | 13,483 |
Shares Outstanding (Diluted) | 16,199 | 16,136 | 14,091 | 13,542 | 13,483 |
Shares Change | 0.39% | 14.51% | 4.06% | 0.44% | 1.17% |
EPS (Basic) | 0.12 | 0.09 | 0.06 | 0.04 | -0.02 |
EPS (Diluted) | 0.12 | 0.09 | 0.06 | 0.04 | -0.02 |
EPS Growth | 34.57% | 41.63% | 58.33% | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 1,228 | 1,376 | 1,057 | 250.08 | 409.43 |
Free Cash Flow Per Share | 0.08 | 0.09 | 0.07 | 0.02 | 0.03 |
Dividend Per Share | 0.059 | - | - | - | - |
Dividend Growth | - | - | - | - | - |
Gross Margin | 23.97% | 24.29% | 21.81% | 21.30% | 19.96% |
Operating Margin | 5.34% | 4.75% | 2.35% | -0.19% | -5.34% |
Profit Margin | 5.65% | 4.68% | 3.27% | 2.00% | -1.29% |
Free Cash Flow Margin | 3.58% | 4.50% | 3.91% | 0.93% | 1.99% |
EBITDA | 1,859 | 1,486 | 658.74 | -24.48 | -1,077 |
EBITDA Margin | 5.43% | 4.86% | 2.44% | -0.09% | -5.23% |
D&A For EBITDA | 30.79 | 32.13 | 23.89 | 27.03 | 21.88 |
EBIT | 1,829 | 1,454 | 634.85 | -51.5 | -1,098 |
EBIT Margin | 5.34% | 4.75% | 2.35% | -0.19% | -5.34% |
Effective Tax Rate | 14.86% | 8.20% | 5.99% | 2.63% | - |